MSI Reproductive Choices

The Chopra Foundation and its Never Alone Initiative, partner with the tech-based social impact start-up, Seva.Love, and The Girl Generation to Launch FGM/C Campaign on this Mental Health Awareness Day

Retrieved on: 
Monday, October 10, 2022
Family, Deepak Chopra, International Day of the Girl Child, Awareness, University, Yoga, Trauma, Girls' Generation, FGM/C, Freedom, The New York Times, Alternative, Survivor, Foundation, Sex, Population Council, ALM, Health minister, Good, Consciousness, NY, Time, Movement, Female, Risk, Woman, Anesthesia, Population, Organization, University of Portsmouth, Multimedia, Technology, Amref Health Africa, Pain, Violence, Seva, Orchid Project, Mental health, International, Non-fungible token, TGG, Meditation, School-related gender-based violence, Data hub, Education, Man, Partnership, MSI Reproductive Choices, MD, Health, FGM, Love, Medicine, Toy, ActionAid, Girl

Despite the nauseating frequency of this practice, FGM/C continues to live in the shadows and receives hardly any representation at the global level.

Key Points: 
  • Despite the nauseating frequency of this practice, FGM/C continues to live in the shadows and receives hardly any representation at the global level.
  • The Chopra Foundation is committed to raising awareness around this brutal custom and eliminating it for all of time."
  • Poonacha Machaiah, CEO the Chopra Foundation and Seva.Love, asserted that "we must make every effort to eradicate this inhumane practice.
  • Seva.Love is championing wellbeing and social impact in Web3 by curating leading artists, influencers, wellbeing experts and creating conscious communities.

Medicines360, MSI Reproductive Choices and MSK Announce Launch of Avibela® Hormonal Intrauterine Device in Kenya

Retrieved on: 
Monday, August 2, 2021
Drugs, Hormonal contraception, Birth control, Health sciences, Intrauterine device, MSI Reproductive Choices, Levonorgestrel, Hormonal IUDs, Long-acting reversible contraception, Marie Stopes

SAN FRANCISCO and LONDON and NAIROBI, Kenya, Aug. 2, 2021 /PRNewswire/ --Medicines360, MSI Reproductive Choices (MSI) and Marie Stopes Kenya (MSK) today announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Kenya.

Key Points: 
  • SAN FRANCISCO and LONDON and NAIROBI, Kenya, Aug. 2, 2021 /PRNewswire/ --Medicines360, MSI Reproductive Choices (MSI) and Marie Stopes Kenya (MSK) today announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Kenya.
  • This is the third launch of Medicines360's hormonal intrauterine device (IUD) in Africa, following Madagascar and Zambia.
  • "Through our partnership with MSI and MSK, women in Kenya will gain increased access to an affordable and effective long-acting reversible contraceptive.
  • Together, Medicines360, MSI and MSK are dedicated to increasing access to the full range of contraceptive options in Kenya and across the globe.

DKT International Breaks Records in 2020 Results for Global Impact on Family Planning

Retrieved on: 
Wednesday, February 24, 2021
AIDS, Social media, Health, Other Health, Pharmaceutical, Other Education, Surgery, Medical devices, Marketing, Infectious diseases, Education, General Health, Communications, Medical Supplies, DKT International, Demography, Unintended pregnancy, Family planning, Abortion, Reproductive health, Unsafe abortion, Health, Birth control, Phil Harvey, MSI Reproductive Choices

DKT International, one of the largest providers of family planning products and services in the developing world, is proud to announce its record-breaking growth in 2020, having served 48.6 million Couple Years Protection (CYPs), which is the estimated protection provided by contraceptive methods during a one-year period based off total contraceptive sales.

Key Points: 
  • DKT International, one of the largest providers of family planning products and services in the developing world, is proud to announce its record-breaking growth in 2020, having served 48.6 million Couple Years Protection (CYPs), which is the estimated protection provided by contraceptive methods during a one-year period based off total contraceptive sales.
  • As one of the largest providers of family planning products and services around the globe, in over 90 countries, DKT continues to deliver contraception and safe abortion products, services, and technology with the support of public health institutions and NGOs, Chris Purdy, CEO of DKT International , shared.
  • According to the MSI Health Impact Calculator, a tool developed to measure the impact of reproductive health programs, DKTs products and services averted an estimated 11.3 million pregnancies, 49,000 maternal deaths, and 12.8 million unsafe abortions.
  • Highlights from DKTs Impact by Country report reveals that DKT Indonesia averted over 1.9 million unintended pregnancies and DKT Nigeria averted over 17,000 child deaths.